Skip to content

-

- - -

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2020-001806-42-IT
Enrollment
438
Registered
2021-01-25
Start date
2020-05-27
Completion date
Unknown
Last updated
2021-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Colchicina LIRCA Product Name: Colchicina LIRCA Product Code: [009964038] Pharmaceutical Form: Tablet INN or Proposed INN: COLCHICINA CAS Number: 64-86-8 Current Sponsor code: - Concentrat

Sponsors

SOCIETA' ITALIANA DI REUMATOLOGIA - SIR
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 219 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 219

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
Main Objective: -;Secondary Objective: -;Primary end point(s): -;Timepoint(s) of evaluation of this end point: -

Secondary

MeasureTime frame
Secondary end point(s): -;Timepoint(s) of evaluation of this end point: -

Countries

Italy

Contacts

Public ContactCarlo Perricone

Reumatologia

carlo.perricone@unipg.it0755783944

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026